The data suggested that VHL plays a key role in UBE2S‐mediated HCC development, in which UBE2S could bind VHL and promote VHL degradation to activate VHL/HIF‐1α signaling and the VHL/JAK2/STAT3 pathway. The gene discussed is STAT3; the disease is hepatocellular carcinoma.